239 related articles for article (PubMed ID: 19634251)
1. Medical use of byproduct material--authorized user clarification. Direct final rule.
Nuclear Regulatory Commission
Fed Regist; 2009 Jul; 74(133):33901-6. PubMed ID: 19634251
[TBL] [Abstract][Full Text] [Related]
2. License terms for medical use licenses--NRC. Final rule.
Fed Regist; 1998 Jun; 63(111):31604-7. PubMed ID: 10180132
[TBL] [Abstract][Full Text] [Related]
3. Quality management program and misadministrations--Nuclear Regulatory Commission. Final rule.
Fed Regist; 1991 Jul; 56(143):34104-22. PubMed ID: 10112867
[TBL] [Abstract][Full Text] [Related]
4. Receipt of byproduct and special nuclear material--NRC. Final rule.
Fed Regist; 1992 Oct; 57(204):47978-83. PubMed ID: 10121919
[TBL] [Abstract][Full Text] [Related]
5. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
[TBL] [Abstract][Full Text] [Related]
6. Institutional Radiation Safety Committee--Nuclear Regulatory Commission. Final rule.
Fed Regist; 1982 Sep; 47(177):40149-50. PubMed ID: 10259789
[TBL] [Abstract][Full Text] [Related]
7. Medical use of byproduct material; proposed revision--NRC. Proposal rule.
Fed Regist; 1998 Aug; 63(156):43516-80. PubMed ID: 10182573
[TBL] [Abstract][Full Text] [Related]
8. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
[TBL] [Abstract][Full Text] [Related]
9. Medical use of byproduct material: issues and request for public input--NRC. Request for public input on rule development.
Fed Regist; 1997 Aug; 62(151):42219-20. PubMed ID: 10169835
[TBL] [Abstract][Full Text] [Related]
10. Medical administration of radiation and radioactive materials--NRC. Final rule.
Fed Regist; 1995 Sep; 60(182):48623-6. PubMed ID: 10151185
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the activity of radiopharmaceutical dosages: Nuclear Regulatory Commission. Proposed rule.
Fed Regist; 1981 Sep; 46(169):43840-2. PubMed ID: 10252126
[TBL] [Abstract][Full Text] [Related]
12. Criteria for the release of individuals administered radioactive materials--NRC. Final rule.
Fed Regist; 1997 Jan; 62(19):4120-33. PubMed ID: 10164806
[TBL] [Abstract][Full Text] [Related]
13. Revision of fee schedules; 100% fee recovery; clarification of size standards--Nuclear Regulatory Commission. Final rule.
Fed Regist; 1991 Nov; 56(219):57587-8. PubMed ID: 10115559
[TBL] [Abstract][Full Text] [Related]
14. Limited revision of fee schedules--NRC. Final rule.
Fed Regist; 1992 Apr; 57(75):13625-34. PubMed ID: 10118460
[TBL] [Abstract][Full Text] [Related]
15. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
[TBL] [Abstract][Full Text] [Related]
16. NRC inspections: risk-informed and performance-based.
Beardsley MR
J Nucl Med Technol; 2008 Sep; 36(3):129-31; quiz 144. PubMed ID: 18703617
[TBL] [Abstract][Full Text] [Related]
17. Quality management program and misadministrations; NRC override of OMB disapproval of NRC information collection request--Nuclear Regulatory Commission. Final rule.
Fed Regist; 1992 Sep; 57(176):41376-8. PubMed ID: 10121196
[TBL] [Abstract][Full Text] [Related]
18. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(147):40858-71. PubMed ID: 10181717
[TBL] [Abstract][Full Text] [Related]
19. Medical use of byproduct material; draft policy statement--NRC. draft policy statement.
Fed Regist; 1998 Aug; 63(156):43580-6. PubMed ID: 10182574
[TBL] [Abstract][Full Text] [Related]
20. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Sep; 63(170):46718. PubMed ID: 10182705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
